The Clinical Trials Arena Excellence Awards Winners have been announced! To see the full list you can download the full 50+ page report from the following link:
The Excellence Awards celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognize the people and companies that are driving change.
Our program is designed to highlight excellence within the sector by looking at a range of corporate activities including deals, business projects and company initiatives, both internal and in the community.
Featured Winners
Linear Clinical Research is an innovative clinical trial organization based in Perth, Western Australia. Linear has completed over 500 trials for international biopharma and a Category Award Winner for Innovation and Marketing.
Novotech is a global contract research organization and a Category Award Winner for Business Expansion, Innovation, and Marketing.
BostonGene is a biotechnology company at the intersection of technology and biology, dedicated to advancing and personalizing cancer medicine. It is also a Category Award Winner for innovation, Product Launches, and Marketing.
EMIS is the UK’s leading integrated healthcare technology provider and a Category Award Winner for Innovation.
ProPharma is a global research consulting company. It helps companies excel at every stage of the pharmaceutical lifecycle and a Category Award Winner for Business Expansion and M&A.
Clinion is a leading global clinical trial company renowned for its award-winning solutions that drive innovation and excellence in the field of clinical research and a Category Award Winner for Innovation.
TrialHub is an NLP and AI-powered data intelligence platform that revolutionises the landscape of clinical trial planning and feasibility analysis. It is also a Category Award Winner for innovation.
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry and a Category Award Winner for Innovation.
Key Trends and Themes
Our research for the 2024 Clinical Trials Arena Excellence Awards revealed the dynamic transformation the pharmaceutical clinical trials industry is undergoing, characterised by a strong focus on business expansion, diversity, environmental sustainability, and technological innovation.
A significant trend noticed is the industry’s commitment to business expansion and strategic growth. Companies like ProPharma and Novotech are leading the way in enhancing clinical trial processes through strategic partnerships and acquisitions. ProPharma’s acquisition of Clinres Farmacija exemplifies successful commercial expansion, broadening service offerings and strengthening competitive positions globally. Similarly, Novotech’s international growth strategy, marked by strategic acquisitions and the launch of the Early Phase Strategic Delivery Unit, highlights its robust global presence and leadership in early-phase clinical development.
Diversity and inclusion remain paramount, with companies like Clario and Parexel setting benchmarks in workforce inclusion and gender equity. Clario’s establishment of a Diversity Council and Parexel’s significant representation of women in their workforce highlight the industry’s dedication to fostering an inclusive environment.
Environmental sustainability is another dominant theme, with AstraZeneca and Celerion at the forefront of pioneering sustainable clinical trials. AstraZeneca’s roadmap to decarbonise clinical trials and Celerion’s alignment with global climate goals reflect a broader industry shift towards eco-friendly practices and resource efficiency.
Technological innovation is driving significant advancements in clinical trials, with companies like IQVIA and TrialHub leveraging artificial intelligence and data-driven solutions to enhance
trial efficiency and patient engagement. IQVIA’s predictive analytics for supply chain management and TrialHub’s AI system for improving trial processes highlight the sector’s focus on integrating cutting-edge technology to drive productivity and innovation. Clinion’s integration of AI and machine learning into its EDC platform further exemplifies the industry’s commitment to enhancing data quality and trial efficiency.
Additionally, companies like BostonGene and EMIS are transforming patient recruitment and data collection, setting new standards for trial execution. BostonGene’s AI-based digital pathology platform and EMIS’s Recruit solution for clinical trial recruitment demonstrate significant advancements in precision medicine and patient engagement.
The awards also highlight the industry’s commitment to social responsibility and community engagement. ICON’s efforts in advancing health equity and Labcorp’s initiatives to expand healthcare access to underserved communities demonstrate a strong commitment to social impact and responsible business practices. Linear Clinical Research’s achievements in improving recruitment analytics and cost efficiency further illustrate the industry’s dedication to optimising clinical trial operations.
Congratulations to all our winners for their outstanding achievements and contributions to advancing the industry!
Awards Report
Our Awards Report contains:
- Introduction and Themes
- All Excellence and Category Winners
- Featured Winner Profiles
- Country Winner Breakdown
You can download the full 50+ page report from the following link: